A 5-year-old child from a slum in Delhi presents with active trachoma (TF stage). The child's family has limited access to healthcare. Which antibiotic regimen is preferred for mass drug administration in this endemic setting?

Explanation

## Azithromycin for Mass Drug Administration in Trachoma ### Why Azithromycin is Preferred for Population-Level Treatment **High-Yield:** In endemic settings with limited healthcare infrastructure, azithromycin is the drug of choice because it can be administered as a **single oral dose** to entire communities, dramatically improving compliance and enabling rapid elimination of active infection. ### Advantages in Mass Drug Administration (MDA) **Key Point:** Azithromycin's suitability for MDA rests on three pillars: 1. **Single-dose regimen** — eliminates adherence burden 2. **Oral route** — no need for trained personnel or sterile equipment 3. **Systemic absorption** — treats both ocular and nasopharyngeal reservoirs, reducing transmission ### Comparison of Regimens in Endemic Settings | Regimen | Dosing | Compliance | Systemic Effect | Cost | Feasibility in Slums | |---------|--------|-----------|-----------------|------|----------------------| | **Azithromycin oral** | Single dose | >90% | Yes | Moderate | Excellent | | Tetracycline ointment | 6 weeks BID | <40% | No | Low | Poor (requires clinic visits) | | Ciprofloxacin topical | 2 weeks QID | <30% | No | Moderate | Poor (frequent dosing) | | Ceftriaxone IM | 4 weeks weekly | <50% | Yes | High | Poor (requires injections) | ### Clinical Pearl: The "A" Strategy in Action **Mnemonic:** **MDA-TF** = Mass Drug Administration for Trachomatous Inflammation-Folding - Administered when TF (trachomatous inflammation–follicular) prevalence ≥5% in children aged 1–9 years - Single oral dose of azithromycin (20 mg/kg) to entire at-risk population - Reduces active infection and transmission within 6–12 months ### Why Other Options Fail in This Context **Warning:** Tetracycline ointment, despite being inexpensive, requires: - Daily clinic visits or supervised application - 6-week commitment (impossible in transient slum populations) - Topical-only effect (nasopharyngeal carriage persists) - Reinfection rates remain high Ciprofloxacin's four-times-daily dosing is incompatible with resource-limited settings where supervised administration is impractical. Ceftriaxone IM is unnecessarily invasive, costly, and offers no advantage over oral azithromycin for this indication. ### Evidence Base **High-Yield:** WHO and international trachoma elimination programs (GET2020, SAFE strategy) have demonstrated that single-dose azithromycin MDA reduces TF prevalence by 60–80% in one round, making it the cornerstone of population-level control in endemic areas.